Filter
1611
Filtered Results: 1611
Text search:
human
pharmaceutical
products
Featured
Recommendations
150
New Publications
452
Language
Document type
No document type
820
Studies & Reports
325
Guidelines
240
Manuals
85
Strategic & Response Plan
83
Fact sheets
21
Training Material
18
Situation Updates
10
Resource Platforms
4
Brochures
2
Infographics
2
Online Courses
1
Countries / Regions
Kenya
66
Global
59
Ethiopia
56
India
51
Sierra Leone
36
Nigeria
35
South Africa
35
Western and Central Europe
32
Uganda
30
Liberia
30
Namibia
29
Ghana
27
Rwanda
27
Nepal
25
Tanzania
23
Zambia
23
Ukraine
19
Philippines
19
Malawi
18
Africa
17
Bangladesh
17
Latin America and the Carribbean
16
Lesotho
13
Eastern Europe
13
Indonesia
13
Zimbabwe
12
Myanmar / Burma
12
Cambodia
11
South–East Asia Region
11
Eswatini/ Swaziland
10
Syria
9
Botswana
9
West and Central Africa
8
Eastern Europe and Central Asia
8
East and Southern Africa
7
Burkina Faso
6
Guinea
6
Haiti
6
Asia
6
Congo, Democratic Republic of
6
South Sudan
5
Cameroon
4
Albania
4
Senegal
4
Venezuela
4
Pakistan
4
North Macedonia
3
Thailand
3
China
3
Fiji
3
Laos
3
Mozambique
3
USA
3
Jordan
3
Middle East and North Africa
3
Western Pacific Region
3
North America
3
Vietnam
3
Russia
3
Sudan
3
Tajikistan
2
Serbia
2
Benin
2
Kyrgyzstan
2
Afghanistan
2
Peru
2
Germany
2
Jamaica
2
Lebanon
2
Papua New Guinea
2
Brazil
2
Moldova
2
Egypt
2
Georgia
2
Central African Republic
2
Mali
2
Timor Leste/ East Timor
1
El Salvador
1
Australia
1
Kazakhstan
1
Iran
1
Niger
1
Uzbekistan
1
Bulgaria
1
Armenia
1
Dominican Republic
1
Ireland
1
Saudi Arabia
1
Gabon
1
Japan
1
Denmark
1
Maldives
1
United Kingdom
1
Southern Africa
1
Belize
1
Costa Rica
1
Panama
1
Nicaragua
1
Sri Lanka
1
Yemen
1
Honduras
1
Angola
1
Libya
1
Bhutan
1
Iraq
1
Somalia
1
Ecuador
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
641
Clinical Guidelines
111
Public Health
84
Key Resources
83
Women & Child Health
42
Pharmacy & Technologies
24
Capacity Building
10
Annual Report MEDBOX
1
Toolboxes
AMR
177
Pharmacy
145
COVID-19
103
TB
76
HIV
71
Mental Health
69
NTDs
56
Rapid Response
53
Planetary Health
52
Global Health Education
38
Caregiver
29
Health Financing Toolbox
28
NCDs
28
Ebola & Marburg
27
Conflict
27
Malaria
17
Specific Hazards
13
Refugee
10
Disability
10
Natural Hazards
8
Polio
8
Social Ethics
3
2.0 Rapid Response
3
Zika
3
Cholera
1
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar...
Antimicrobial resistance (AMR) is occurring everywhere in the world, compromising the ability to treat infectious diseases, as well as undermining many other advances in health and medicine. Underlying factors that drive AMR include; weak or absent surveillance and monitoring systems, inadequate sys...
Namibia guideline for submission of applications for registration of pharmaceuticals for human use in common technical document format.
This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and manufacturers; purchase of pharmaceutical products; storage of pharmaceutical products; and distribut...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
The management of information and logistics is an essential component of health product systems. In a context of limited financial resources and morbidity and mortality sustained by persistent diseases, it is necessary to strengthen health systems through competent resources, especially human resour...
This curricula guide builds on several existing products of WHO and partners, aimed at supporting countries in their effort to address the first objective of the GAP-AMR (to improve awareness and understanding of AMR). It is targeted specifically at health educators and policy planners, and applies ...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells...
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to...
Phil. Trans. R. Soc. B (2010) 365, 2959–2971; doi:10.1098/rstb.2010.0143.
Agricultural ecosystems provide humans with food, forage, bioenergy and pharmaceuticals and are essential to human wellbeing. These systems rely on ecosystem services provided by natural ecosystems, including pollination, b...
China is one of the major countries for the production and use of antibacterial agents. Antibacterial agents are widely used in healthcare and animal husbandry. It plays a significant role in treating infections and saving patient lives, preventing and treating animal diseases, improving farming ef...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
MICROBIAL DRUG RESISTANCEVolume 24, Number 5, 2018ªMary Ann Liebert, Inc.DOI: 10.1089/mdr.2017.0383
Antibiotic resistance (ABR) is a worldwide publichealth concern, with serious health, economic, and so-cietal repercussions. Its emergence is attributed to the se-lective pressure exerted by antib...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality. ...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
Revision Bulletin ESPNF
First edition, November 1997 | Revised July 2002
Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.
